Chewy Inc vs Stryker Corporation — how do they compare? Chewy Inc trades at $20.38 (market cap $8.32B), while Stryker Corporation trades at $311.07 (market cap $127.06B). The key difference: Stryker Corporation is far larger — about 15.3× Chewy Inc's market cap, and Stryker Corporation pays a 1.06% dividend while Chewy Inc pays none. Which is the better fit depends on your goals.
| CHWY | SYK | |
|---|---|---|
Market Cap | $8.32B | $127.06B |
Sector | Consumer Cyclical | Technology |
52-Week High | $42.33 | $403.53 |
52-Week Low | $17.51 | $282.58 |
Enterprise Value | $8.28B | $138.82B |
Dividend Yield | — | 1.06% |
Signals from Pluang's Aura AI — not financial advice
Chewy (CHWY) trades at $20.32, down 2.68% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported $11.86B revenue for 2025 with net income of $392.74M, showing improved profitability. Recent news highlights expansion in pet healthcare and AI-driven operational efficiency, though Q1 2026 earnings missed expectations.
The outlook is mixed: strong analyst consensus (81.58% buy ratings) and a $34.92 price target suggest upside, but near-term risks include consumer trade-down pressures and competitive threats. Long-term growth drivers in pet care and margin expansion offer potential, yet macroeconomic headwinds and execution risks warrant caution.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Read more on CHWY →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →